Drug‐drug interactions between feminizing hormone therapy and pre‐exposure prophylaxis among transgender women: the iFACT study

INTRODUCTION: Concerns over potential drug‐drug interactions (DDI) between feminizing hormone therapy (FHT) and pre‐exposure prophylaxis (PrEP) have hampered uptake and adherence of PrEP among transgender women (TGW). To determine DDI between FHT and PrEP, we measured the pharmacokinetic (PK) parame...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Int AIDS Soc
Main Authors: Hiransuthikul, Akarin, Janamnuaysook, Rena, Himmad, Kanittha, Kerr, Stephen J, Thammajaruk, Narukjaporn, Pankam, Tippawan, Phanjaroen, Kannapat, Mills, Stephen, Vannakit, Ravipa, Phanuphak, Praphan, Phanuphak, Nittaya
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6625338/
https://ncbi.nlm.nih.gov/pubmed/31298497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jia2.25338
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados